Bioceres Crop Solutions (BIOX) Net Income towards Common Stockholders (2016 - 2026)

Bioceres Crop Solutions has reported Net Income towards Common Stockholders for 11 years, with the latest figure at -$12.4 million in Q1 2026.

• Quarterly Net Income towards Common Stockholders fell 576.92% year-over-year to -$12.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$242.3 million (down 14049.78% YoY) and the FY2025 annual result came in at -$55.4 million, down 1396.07% from the prior year.
• Net Income towards Common Stockholders grew to -$12.4 million in Q1 2026 per BIOX's latest filing, from -$178.0 million in the prior quarter.
• Over five years, Net Income towards Common Stockholders peaked at $28.2 million in Q1 2023 and troughed at -$178.0 million in Q4 2025.
• A 5-year average of -$13.3 million and a median of -$5.1 million in 2022 frame the typical range for Net Income towards Common Stockholders.
• The sharpest annual moves came in 2023 and 2025: Net Income towards Common Stockholders surged 534.83% in 2023, then sank 4822.22% in 2025.
• Over 5 years, Net Income towards Common Stockholders stood at -$8.2 million in 2022, then jumped by 115.18% to $1.2 million in 2023, then jumped by 420.96% to $6.5 million in 2024, then plunged by 2858.71% to -$178.0 million in 2025, then surged by 93.03% to -$12.4 million in 2026.
• According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$12.4 million, -$178.0 million, and -$7.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.